Plymouth, MI – According to filings with the U.S. Securities and Exchange Commission, Phenomics Health is raising $19,504,500.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, James Burns played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Phenomics Health
We are a bioinformatics-based precision medicine platform company translating patient-specific and population-based medical big data into novel pharmacological clinical treatment decision support products and services. We offer a proprietary technology, the PredictMed Platform, designed to help clinicians and health systems optimize precision in the selection of appropriate medications, drug combinations and dosages that improve each patients health, while also reducing adverse reactions. Our PrecsMed platform represents a significant step forward in accurately assessing a patients complete medication profile. Physicians can finally see the full spectrum of medications present in the patient, and identify appropriate dosing levels for therapeutic effectiveness. PrecsMed can accurately assess prescribing trends, medication adherence and EHR coverage, as well as define medication concentrations in patients with comorbid disorders.

To learn more about Phenomics Health, visit http://www.phenomicshealth.com/

Contact:
James Burns, Chief Executive Officer
734-233-3070

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved